Invitation

January 9, 2014 Rundbuckstrasse 6

CH - 8212 Neuhausen am Rheinfall / Switzerland www.lifewatch.com

Invitation to the Ordinary General Meeting of Shareholders of LifeWatch Ltd. January 30, 2014 at 10:00 a.m. (doors open at 09:30 a.m.) at TECHNOPARK Zurich, Technoparkstrasse 1, CH-8005 Zürich Agenda

1. Approval of the Annual Report, Statutory Annual Financial Statements and Consolidated

Financial Statements 2012

2. Allocation of Balance Sheet Result

3. Grant Discharge to the members of the Board of Directors and members of the Executive

Board

4. Amendments of the Articles of Incorporation

5. Revision of the Articles in order to implement the Ordinance against Excessive Compensa- tions in listed Stock Corporations

6. Re-election of the current five members of the Board of Directors

7. Election of new members of the Board of Directors

8. Election of the Chairman of the Board of Directors

9. Election of the members of the Compensation Committee

10. Election of the Independent Shareholder Representative

11. Election of the Statutory Auditors

12. Compensations

The full content of the agenda and the motions of the Board of Directors can be found in the en- closed PDF or in the Investor Relations section of the LifeWatch website under http://www.irlifewatch.com/corporate-governance/agm-and-egm.aspx

Notifications

The Annual Report, the Statutory Annual Financial Statements and the Consolidated Financial Statements, the Reports of the Auditors as well as the Minutes of the Ordinary General Meeting of June 28, 2012 and the Extraordinary General Meeting of January 23, 2013 are at the sharehold- ers` disposal. Upon request, a shareholder may receive a copy of the Annual Report or of the oth-

LifeWatch AG January 9, 2014

er documents mentioned above, from the Company. Since April 30, 2013, the Annual Report 2012 can be downloaded from the Company`s website www.lifewatch.com.

Shareholders registered in the Company`s shareholders` register before January 27, 2014, which is the first day of the closing period of the share register, will receive an invitation including a reply and proxy form (registration/power of attorney to the Ordinary General Meeting) as well as the completed instruction form to the independent shareholder representative (cf. below regarding the person of the individual shareholder representative). Shareholders will receive an admission card provided that they request one by using their reply form. Shareholders may also obtain admission cards at the admission desk opening half an hour prior to the Ordinary General Meeting upon presentation of the reply form.

The shareholders` register will be closed as of January 27, 2014 until and including January 30,

2014. During this period, no modifications to the share register will take place.

A Shareholder who is unable to attend the Ordinary General Meeting may vote by appointing a third party as his or her proxy. This person does not need to be a shareholder. In this case, the shareholder shall request an admission card and forward it duly filled-out and signed to the proxy.

Alternatively, a shareholder may also instruct the independent shareholder representative pursuant to Art. 689c of the Swiss Code of Obligations and Art. 8 of the Ordinance against Excessive Com- pensations, Mr. lic. iur. Yves Endrass, Attorney at law with Stiffler & Partner, Rechtsanwälte, Dufourstrasse 101, P.O. Box. 1072, CH-8034 Zurich, email: unab.lifewatch@sharecomm.ch, to exercise his or her vote by returning the filled-out and signed reply and proxy form as well as the completed and signed instruction form. In the event that he receives no instructions, the independ- ent shareholder representative will abstain from voting. In the event that the independent share- holder representative is appointed as proxy, the filled-out and signed reply and proxy form includ- ing the filled-out and signed instruction form may also be scanned and be sent by email to un- ab.lifewatch@sharecomm.ch.

In case that a proxy is granted to the independent shareholder representative, no admission card has to be requested, but the return of the filled-out and signed reply and proxy form as well as the completed and signed instruction form by mail or email is sufficient.

For further information please contact:

Sensus Communication Consultants, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss Exchange (LIFE), Swit- zerland, is the leading healthcare technology and solution company, specializing in advanced telehealth systems and wireless remote patient monitoring services. LifeWatch services cater to individuals, ranging from high-risk and chronically ill patients, to consumers of health and wellness products. LifeWatch AG has operative subsidiaries in the United States, in Switzerland and in Israel and is the parent company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading US-based provider of cardiac monitoring services and home sleep testing of Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is a leading developer and manufacturer of telemedicine prod- ucts. The Company is planning to introduce the LifeWatch V, an Android-based smartphone with medical sensors and apps that uses a cloud-based service platform. For additional information, please visit www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is available at http://www.irlifewatch.com/alert-service.aspx

This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, business strategy and plans and objectives for future operations, are forward-looking statements.
LifeWatch AG January 9, 2014 2
The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expres- sions are intended to identify forward-looking statements. LifeWatch AG has based these forward-looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short term and long term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. All forward-looking state- ments are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCU- LATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PER- SONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECU- RITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CON- TAIN DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINAN- CIAL STATEMENTS OF THE ISSUER.
LifeWatch AG January 9, 2014 3

distributed by